Rufeng Dai
Impact in
-
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Lipid metabolism and disorders
Papers in
-
- Lipid metabolism and disorders 7
-
- Renal and related cancers 6
- Single-cell and spatial transcriptomics 1
- Co-authors
- Yihui Zhai (7 shared papers)Haimei Liu (6 shared papers)Hong Xu (6 shared papers)Jia Rao (6 shared papers)Xiliang Zha (1 shared paper)Yi Lin (1 shared paper)Xiaoyan Fang (3 shared papers)Qian Shen (9 shared papers)
- Journals
- BMC Nephrology (3 papers)Frontiers in Pediatrics (1 paper)Human Genomics (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Rufeng Dai
10 papers receiving 71 citations
Peers
Comparison fields: 5 of 24
- Nephrology 39
- Cardiology and Cardiovascular Medicine 42
- Cancer Research 8
- Endocrinology, Diabetes and Metabolism 7
- Molecular Biology 23
Countries citing papers authored by Rufeng Dai
This map shows the geographic impact of Rufeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufeng Dai more than expected).
Fields of papers citing papers by Rufeng Dai
This network shows the impact of papers produced by Rufeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufeng Dai. The network helps show where Rufeng Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Rufeng Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 30 | |
| 2 | 2019 | 15 | |
| 3 | 2019 | 5 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2015 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2024 | 0 |
About Rufeng Dai
Rufeng Dai is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Nephrology, Surgery and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 71 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (7 papers), Renal Diseases and Glomerulopathies (6 papers), Renal and related cancers (6 papers), Chronic Kidney Disease and Diabetes (4 papers), Renal cell carcinoma treatment (3 papers), Pediatric Urology and Nephrology Studies (2 papers), Pancreatic function and diabetes (2 papers) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Nephrology (39 citations), Cardiology and Cardiovascular Medicine (42 citations), Cancer Research (8 citations), Endocrinology, Diabetes and Metabolism (7 citations) and Molecular Biology (23 citations). Rufeng Dai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yihui Zhai, Haimei Liu, Hong Xu, Jia Rao, Xiliang Zha, Yi Lin, Xiaoyan Fang, Qian Shen, Junchao Liu and Makiko Nakayama. Their work appears in journals such as BMC Nephrology, Frontiers in Pediatrics, Human Genomics, Frontiers in Cell and Developmental Biology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.